GAL and infection: We also demonstrated that the administration of the exogenous galanin analogue NAX 5055 into galanin-deficient larvae reduced the progression of infection and lowered mortality after caudal vein infection with both pathogens; however, the treatment was barely effective after yolk infection with S. aureus, where mortality exceeded 80% after 16 hpi.